Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03143920 · ClinicalTrials.gov registry record · Early Phase 1
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
A Early Phase 1 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT03143920 is a Early Phase 1 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 11 participants.
The verdict
NCT03143920, a Early Phase 1 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Pilot study to determine feasibility for treating patients with two chronic inflammatory conditions of the urinary bladder: chronic interstitial cystitis and recurrent urinary tract infections using a standardized hyperbaric oxygen treatment plan. Presently there are no good treatments for these conditions and hyperbaric oxygen may be a safe and readily accessible therapy as it has proven successful an another type of chronic inflammatory condition of the urinary bladder known as "radiation cystitis". The study will determine if patients will consider this an acceptable treatment for their conditions and that it is well tolerated.
Interventions
- COMBINATION_PRODUCT Hyperbaric Oxygen Therapy-
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2022-07-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03143920
The ClinicalTrials.gov registry entry for NCT03143920 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy- is the first listed.
NCT03143920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03143920 about?
NCT03143920 is a clinical study titled "Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder". Pilot study to determine feasibility for treating patients with two chronic inflammatory conditions of the urinary bladder: chronic interstitial cystitis and recurrent urinary tract infections using a standardized hyperbaric oxygen treatment plan. Presently there are no good treatments for these con...
What is the current status of trial NCT03143920?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2017-11-01. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT03143920?
The interventions under investigation include: Hyperbaric Oxygen Therapy- (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03143920?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.